imiquimod has been researched along with Diffuse Large B-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukai, S; Fukushi, M; Hanada, K; Iio, K; Irie, T; Komakura, K; Mizukami, Y; Obika, S; Ohtake, F; Oikawa, D; Phuong, HT; Saeki, Y; Sakamoto, S; Sato, Y; Sugawara, K; Tanaka, K; Terawaki, S; Tokunaga, F; Tsuruta, D | 1 |
| Duvic, M; Hicks, LD | 1 |
2 other study(ies) available for imiquimod and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Molecular bases for HOIPINs-mediated inhibition of LUBAC and innate immune responses.
Topics: A549 Cells; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Disease Models, Animal; Enzyme Inhibitors; Female; HEK293 Cells; HeLa Cells; Humans; Imiquimod; Immunity, Innate; Inflammation Mediators; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred BALB C; Molecular Structure; Psoriasis; Signal Transduction; Structure-Activity Relationship; Transcription Factors; Ubiquitin-Protein Ligases; Ubiquitins | 2020 |
Wiskott-Aldrich syndrome and molluscum contagiosum: a therapeutic challenge after reaction to cidofovir.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Oral; Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance; Humans; Imiquimod; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Molluscum Contagiosum; Organophosphonates; Wiskott-Aldrich Syndrome | 2008 |